Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tax inversions
tax inversions
Actelion Says U.S. Tax-Inversion Limits Good for Industry
Bloomberg
Tue, 10/21/14 - 08:05 am
Actelion
tax inversions
M&A
AbbVie says $55 billion acquisition of Shire officially dead
Yahoo/Reuters
Mon, 10/20/14 - 06:36 pm
AbbVie
Shire
M&A
tax inversions
AbbVie Board Recommends Holders Vote Against Shire Deal
Bloomberg
Thu, 10/16/14 - 07:47 am
AbbVie
Shire
tax inversions
M&A
AbbVie, Shire Have Options Besides Each Other: Real M&A
Bloomberg
Wed, 10/15/14 - 02:54 pm
M&A
AbbVie
Shire
tax inversions
Allergan
Valeant Pharmaceuticals
What Does Closing the ‘Double Irish’ Tax Loophole Mean for Pharma?
WSJ Pharmalot
Wed, 10/15/14 - 11:33 am
Ireland
tax inversions
Shire says AbbVie should not renege on merger deal
Yahoo/Reuters
Wed, 10/15/14 - 08:07 am
Shire
AbbVie
M&A
tax inversions
Steris to spend $1.9B on UK's Synergy Health
Yahoo/AP
Mon, 10/13/14 - 07:22 am
Steris
Synergy Health
M&A
tax inversions
Dealpolitik: Allergan Battle May Showcase Unintended Consequences of Inversion Rules
WSJ Online
Wed, 10/8/14 - 01:10 pm
Allergan
Valeant Pharmaceuticals
M&A
tax inversions
Is Teva knocking on Mylan's door? With inversion deal at risk, maybe
Fierce Pharma
Mon, 10/6/14 - 06:45 pm
Teva Pharmaceutical
Mylan Labs
tax inversions
M&A
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Bidness Etc.
Wed, 10/1/14 - 08:09 am
tax inversions
intellectual property
Gilead Sciences
Alexion
AbbVie Said to Weigh More Shire Financing After U.S. Rule
Bloomberg
Fri, 09/26/14 - 10:47 am
AbbVie
Shire
tax inversions
M&A
AbbVie May Be Next Big Loser In Tax Inversion Race
Bidness Etc.
Thu, 09/25/14 - 09:49 am
AbbVie
tax inversions
Shire
M&A
Medtronic May Be The Biggest Loser In The Tax Inversion Race After New Tax Rules By The US Treasury
Bidness Etc.
Wed, 09/24/14 - 08:37 am
Medtronic
tax inversions
M&A
Covidien
devices
Pfizer explored takeover of rival Actavis
Marketwatch
Wed, 09/24/14 - 07:54 am
Pfizer
Actavis
tax inversions
M&A
Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ
Fierce Pharma
Tue, 09/23/14 - 05:45 pm
Mylan Labs
Pfizer
AstraZeneca
Shire
AbbVie
tax inversions
Abbott Labs
U.S. Rule Targets Medtronic Tax-Free Use of Foreign Cash
Bloomberg
Tue, 09/23/14 - 09:56 am
Medtronic
tax inversions
devices
Who loses in biopharma as Treasury moves to block tax inversions?
Fierce Biotech
Tue, 09/23/14 - 08:00 am
tax inversions
Pfizer
Shire
AstraZeneca
AbbVie
Salix
Inversion Deal Crackdown Sends AstraZeneca, Shire Down
Bloomberg
Tue, 09/23/14 - 07:37 am
AstraZeneca
Shire
tax inversions
Merck's Mantra On Focus Precludes An Inversion Strategy
Forbes
Mon, 09/15/14 - 08:47 am
Merck
tax inversions
Keytruda
melanoma
Pfizer CEO is Still Weighing Inversion Deals
WSJ Online
Fri, 09/12/14 - 08:11 pm
Pfizer
Ian Read
Pharma CEOs
tax inversions
M&A
AstraZeneca
Actavis
Pages
« first
‹ previous
1
2
3
4
next ›
last »